Targeting P13K/AKT-dependent cellular senescence to treat cancer

Lead researcher

Prof Richard Pearson, Dr Katherine Hannan


The University of Melbourne

Years funded


This project investigates new ways to arrest the growth of cancer cells by re-activating a checkpoint that protects normal cells from becoming cancerous. It will lead to new treatments for a range of cancer types.

Lay Report

Funding Body

Cancer Council Research Grant


$100,000 per annum